Anti-BAALC antibodies are used in the immunodetection of the protein BAALC binder of MAP3K1 and KLF4. In humans, the canonical protein has a reported length of 145 amino acid residues and a mass of 15.6 kDa. Its subcellular localization is in the cytoplasm. Up to 6 different isoforms have been reported for this protein. It is reported to be highly expressed in the neuroectoderm-derived tissues. BAALC is believed to play a synaptic role at the postsynaptic lipid rafts possibly through interaction with CAMK2A. Post-translational modifications have been described, including palmitoylation and myristoylation. Synonyms for this target antigen include BAALC, MAP3K1 and KLF4 binding, BAALC, MEKK1 and KLF4 binding, brain and acute leukemia, cytoplasmic, and brain and acute leukemia cytoplasmic protein. BAALC gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some BAALC antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.